Advanced cell-based therapies are promising approaches for stimulating full regeneration of
cartilage lesions. In addition to a few commercially available medicinal products, several …

Damage to cartilage represents one of the most challenging tasks of musculoskeletal
therapeutics due to its limited propensity for healing and regenerative capabilities. Lack of …

Human mesenchymal stem/stromal cells (hMSCs) present a key therapeutic cellular
intervention for use in cell and gene therapy (CGT) applications due to their …

Due to their unique features, mesenchymal stem/stromal cells (MSC) have been exploited in
clinical settings as therapeutic candidates for the treatment of a variety of diseases …

Millions of people worldwide suffer from trauma-or age-related orthopedic diseases such as
osteoarthritis, osteoporosis, or cancer. Tissue Engineering (TE) and Regenerative Medicine …

Mesenchymal stem/stromal cells (MSC) are being widely explored as promising candidates
for cell‐based therapies. Among the different human MSC origins exploited, umbilical cord …

The extracellular matrix (ECM) is a highly dynamic and complex meshwork of proteins and
glycosaminoglycans (GAGs) with a crucial role in tissue homeostasis and organization not …

Therapies using human mesenchymal stem cells (MSCs) combined with three-dimensional
(3D) printed scaffolds are a promising strategy for bone grafting. But the harvest of MSCs still …

Umbilical cord matrix (UCM)‐derived mesenchymal stem/stromal cells (MSCs) are
promising therapeutic candidates for regenerative medicine settings. UCM MSCs have …

Mesenchymal stromal cells (MSCs) can be isolated from various tissues of healthy or patient
donors to be retransplanted in cell therapies. Because the number of MSCs obtained from …